NeuroPaces SWOT analysis epilepsy treatment innovators stock poised for growth - Investing.com
| NPCE Stock | USD 13.76 0.43 3.03% |
About 62% of Neuropace's investor base is looking to short. The analysis of overall sentiment of trading Neuropace stock suggests that many investors are alarmed at this time. The current market sentiment, together with Neuropace's historical and current headlines, can help investors time the market. In addition, many technical investors use Neuropace stock news signals to limit their universe of possible portfolio assets.
Neuropace |
NeuroPaces SWOT analysis epilepsy treatment innovators stock poised for growth Investing.com
Read at news.google.com
 |
Neuropace Fundamental Analysis
We analyze Neuropace's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Neuropace using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Neuropace based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Neuropace is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Neuropace Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Neuropace stock to make a market-neutral strategy. Peer analysis of Neuropace could also be used in its relative valuation, which is a method of valuing Neuropace by comparing valuation metrics with similar companies.
Peers
Neuropace Related Equities
| CNMD | CONMED | 1.30 | ||||
| FNA | Paragon 28 | 0.08 | ||||
| LUNG | Pulmonx Corp | 0.18 | ||||
| GKOS | Glaukos Corp | 0.83 | ||||
| ITGR | Integer Holdings | 0.90 | ||||
| ANIK | Anika Therapeutics | 1.27 | ||||
| AORT | Artivion | 1.31 | ||||
| OFIX | Orthofix Medical | 1.72 | ||||
| IRMD | Iradimed | 1.82 | ||||
| ELMD | Electromed | 2.11 | ||||
| NVRO | Nevro Corp | 2.69 | ||||
| KIDS | Orthopediatrics Corp | 2.82 | ||||
| SRDX | SurModics | 4.06 | ||||
| CVRX | CVRx | 4.94 |
Complementary Tools for Neuropace Stock analysis
When running Neuropace's price analysis, check to measure Neuropace's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuropace is operating at the current time. Most of Neuropace's value examination focuses on studying past and present price action to predict the probability of Neuropace's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuropace's price. Additionally, you may evaluate how the addition of Neuropace to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |